01 3Syprine
Main Therapeutic Indication : Genetic Disorders
Currency : USD
2016 Revenue in Millions : 88
2015 Revenue in Millions : 89
Growth (%) : -1
Main Therapeutic Indication : Genetic Disorders
Currency : USD
2017 Revenue in Millions : 91
2016 Revenue in Millions : 88
Growth (%) : 3
Main Therapeutic Indication : Genetic Disorders
Currency : USD
2018 Revenue in Millions : 47
2017 Revenue in Millions : 91
Growth (%) : -48%
LOOKING FOR A SUPPLIER?